世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
子宮内避妊具市場：タイプ別（非ホルモン性：銅含有IUD、ホルモン性：黄体ホルモン放出IUD）、年齢層別（15～24歳、25～34歳、35～44歳、44歳以上）、エンドユーザー別（病院、クリニック、地域医療センター、その他）。世界の機会分析および産業予測、2021-2031年Intrauterine Devices Market By Type (Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing IUD), By Age Group (15-24 years, 25-34 years, 35-44 years, Above 44 years), By End User (Hospitals, Clinics, Community Health Care Centres, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 子宮内避妊具の世界市場は、2021年に29億9,273万ドルで、2022年から2031年にかけてCAGR3.8%を記録し、2031年には43億7,430万ドルに達すると予測されています。子宮内避妊器具（IUD）は、避妊のために使用される小... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー子宮内避妊具の世界市場は、2021年に29億9,273万ドルで、2022年から2031年にかけてCAGR3.8%を記録し、2031年には43億7,430万ドルに達すると予測されています。子宮内避妊器具（IUD）は、避妊のために使用される小型のプラスチック製T字型デバイスです。子宮内に挿入され、妊娠を防ぐために留置されます。子宮内避妊器具は、長時間作用型可逆的避妊法（LARC）の一つで、思春期の子どもや子どもを持ったことがない人にも安全で効果的です。子宮内避妊具を取り外すと、たとえ長期間使用していても、生殖能力は急速に元に戻ります。子宮内避妊器具には、望まない妊娠を防ぐために、非ホルモン性：銅含有IUDとホルモン性：黄体ホルモン放出型IUDの2種類が市販されています。子宮内避妊器具の世界市場は、タイプ、年齢層、エンドユーザー、地域によって区分されます。タイプ別では、非ホルモン性：銅含有IUDとホルモン性：プロゲストーゲン放出IUDに分類されます。年齢層別では、15～24歳、25～34歳、35～44歳、44歳以上に分類されます。エンドユーザー別では、病院、地域医療センター、診療所、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAの4地域に分けて分析されています。 市場成長の主な要因は、家族計画への注目の高まりと、意図しない妊娠を防ぐ必要性です。効果が向上し、副作用の少ないホルモン性子宮内避妊具の進歩は、市場の成長をさらに押し上げると予想されます。また、10代の妊娠に関連する健康問題は、計画外の妊娠を防ぐために、子宮内装置法のメソッドの意識の高まりは、市場の成長を促進する。しかし、避妊具の使用に伴う健康リスクや、社会的受容性の欠如は、市場成長に悪影響を及ぼします。 世界の子宮内避妊具市場で動作する主要なプレーヤーは、AbbVie社（Allergan Plc）、バイエル社、クーパー社、DKTインターナショナル、モナリザNV（EurimPharmaグループ）、Oconヘルスケア、Pregana International Ltd、Prosan International B.V. 、Eurogine SL、Viatrisが含まれています。Eurogine SL、Viatris Inc. (Mylan NV)。 2021年、アジア太平洋地域は、多くの人口の存在、ホルモン性子宮内避妊具を使用する利点の認知度の増加、望まない妊娠の高い有病率、有利な規制シナリオにより、主要な収益源となりました。しかし、北米は、医療インフラの存在とIUDの使用に関連する認知度の上昇により、2021年に2番目に大きな収益源となっています。 ステークホルダーにとっての主なメリット 当レポートでは、2021年から2031年までの子宮内避妊具市場の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、子宮内避妊具市場の有力なビジネスチャンスを特定することができます。 ●市場調査は、主要な推進要因、抑制要因、機会に関連する情報とともに提供されます。 ポーターのファイブフォース分析により、買い手と供給者の潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、供給者と買い手のネットワークを強化できるようにします。 子宮内避妊具市場のセグメンテーションの詳細な分析により、市場機会を決定することができます。 子宮内避妊具市場の詳細な分析は、市場機会を決定するのに役立ちます。 市場プレイヤーのポジショニングにより、ベンチマークを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。 子宮内避妊器具の地域別、世界別の市場動向、キープレイヤー、市場セグメント、応用分野、市場成長戦略などの分析が含まれています。 主な市場セグメント タイプ別 非ホルモン性銅含有IUD ホルモン剤黄体ホルモン放出型IUD 年齢層別 25-34歳 35-44歳 44歳以上 15-24歳 エンドユーザー別 病院 診療所 地域医療センター その他 地域別 北米 米国 カナダ メキシコ 欧州 ドイツ フランス イギリス イタリア スペイン その他の地域 アジア・パシフィック 日本 中国 オーストラリア インド 韓国 その他のアジア太平洋地域 LAMEA ブラジル サウジアラビア 南アフリカ LAMEAの残りの地域 主な市場関係者 バイエル クーパーサージカル社 DKTインターナショナル モナリザNV プレグナ・インターナショナル・リミテッド プロサンインターナショナルBV アブビー社 ○ Eurogine, S.L. ヴィアトリス・インク ○ モナリザN.V, 目次CHAPTER 1:INTRODUCTION1.1.Report description 1.2.Key market segments 1.3.Key benefits to the stakeholders 1.4.Research Methodology 1.4.1.Secondary research 1.4.2.Primary research 1.4.3.Analyst tools and models CHAPTER 2:EXECUTIVE SUMMARY 2.1.Key findings of the study 2.2.CXO Perspective CHAPTER 3:MARKET OVERVIEW 3.1.Market definition and scope 3.2.Key findings 3.2.1.Top investment pockets 3.3.Porter’s five forces analysis 3.4.Top player positioning 3.5.Market dynamics 3.5.1.Drivers 3.5.2.Restraints 3.5.3.Opportunities 3.6.COVID-19 Impact Analysis on the market CHAPTER 4: INTRAUTERINE DEVICES MARKET, BY TYPE 4.1 Overview 4.1.1 Market size and forecast 4.2 Nonhormonal: Copper-containing IUD 4.2.1 Key market trends, growth factors and opportunities 4.2.2 Market size and forecast, by region 4.2.3 Market analysis by country 4.3 Hormonal: Progestogen-releasing IUD 4.3.1 Key market trends, growth factors and opportunities 4.3.2 Market size and forecast, by region 4.3.3 Market analysis by country CHAPTER 5: INTRAUTERINE DEVICES MARKET, BY AGE GROUP 5.1 Overview 5.1.1 Market size and forecast 5.2 15-24 years 5.2.1 Key market trends, growth factors and opportunities 5.2.2 Market size and forecast, by region 5.2.3 Market analysis by country 5.3 25-34 years 5.3.1 Key market trends, growth factors and opportunities 5.3.2 Market size and forecast, by region 5.3.3 Market analysis by country 5.4 35-44 years 5.4.1 Key market trends, growth factors and opportunities 5.4.2 Market size and forecast, by region 5.4.3 Market analysis by country 5.5 Above 44 years 5.5.1 Key market trends, growth factors and opportunities 5.5.2 Market size and forecast, by region 5.5.3 Market analysis by country CHAPTER 6: INTRAUTERINE DEVICES MARKET, BY END USER 6.1 Overview 6.1.1 Market size and forecast 6.2 Hospitals 6.2.1 Key market trends, growth factors and opportunities 6.2.2 Market size and forecast, by region 6.2.3 Market analysis by country 6.3 Clinics 6.3.1 Key market trends, growth factors and opportunities 6.3.2 Market size and forecast, by region 6.3.3 Market analysis by country 6.4 Community Health Care Centres 6.4.1 Key market trends, growth factors and opportunities 6.4.2 Market size and forecast, by region 6.4.3 Market analysis by country 6.5 Others 6.5.1 Key market trends, growth factors and opportunities 6.5.2 Market size and forecast, by region 6.5.3 Market analysis by country CHAPTER 7: INTRAUTERINE DEVICES MARKET, BY REGION 7.1 Overview 7.1.1 Market size and forecast 7.2 North America 7.2.1 Key trends and opportunities 7.2.2 North America Market size and forecast, by Type 7.2.3 North America Market size and forecast, by Age Group 7.2.4 North America Market size and forecast, by End User 7.2.5 North America Market size and forecast, by country 7.2.5.1 U.S. 7.2.5.1.1 Market size and forecast, by Type 7.2.5.1.2 Market size and forecast, by Age Group 7.2.5.1.3 Market size and forecast, by End User 7.2.5.2 Canada 7.2.5.2.1 Market size and forecast, by Type 7.2.5.2.2 Market size and forecast, by Age Group 7.2.5.2.3 Market size and forecast, by End User 7.2.5.3 Mexico 7.2.5.3.1 Market size and forecast, by Type 7.2.5.3.2 Market size and forecast, by Age Group 7.2.5.3.3 Market size and forecast, by End User 7.3 Europe 7.3.1 Key trends and opportunities 7.3.2 Europe Market size and forecast, by Type 7.3.3 Europe Market size and forecast, by Age Group 7.3.4 Europe Market size and forecast, by End User 7.3.5 Europe Market size and forecast, by country 7.3.5.1 Germany 7.3.5.1.1 Market size and forecast, by Type 7.3.5.1.2 Market size and forecast, by Age Group 7.3.5.1.3 Market size and forecast, by End User 7.3.5.2 France 7.3.5.2.1 Market size and forecast, by Type 7.3.5.2.2 Market size and forecast, by Age Group 7.3.5.2.3 Market size and forecast, by End User 7.3.5.3 U.K. 7.3.5.3.1 Market size and forecast, by Type 7.3.5.3.2 Market size and forecast, by Age Group 7.3.5.3.3 Market size and forecast, by End User 7.3.5.4 Italy 7.3.5.4.1 Market size and forecast, by Type 7.3.5.4.2 Market size and forecast, by Age Group 7.3.5.4.3 Market size and forecast, by End User 7.3.5.5 Spain 7.3.5.5.1 Market size and forecast, by Type 7.3.5.5.2 Market size and forecast, by Age Group 7.3.5.5.3 Market size and forecast, by End User 7.3.5.6 Rest of Europe 7.3.5.6.1 Market size and forecast, by Type 7.3.5.6.2 Market size and forecast, by Age Group 7.3.5.6.3 Market size and forecast, by End User 7.4 Asia-Pacific 7.4.1 Key trends and opportunities 7.4.2 Asia-Pacific Market size and forecast, by Type 7.4.3 Asia-Pacific Market size and forecast, by Age Group 7.4.4 Asia-Pacific Market size and forecast, by End User 7.4.5 Asia-Pacific Market size and forecast, by country 7.4.5.1 Japan 7.4.5.1.1 Market size and forecast, by Type 7.4.5.1.2 Market size and forecast, by Age Group 7.4.5.1.3 Market size and forecast, by End User 7.4.5.2 China 7.4.5.2.1 Market size and forecast, by Type 7.4.5.2.2 Market size and forecast, by Age Group 7.4.5.2.3 Market size and forecast, by End User 7.4.5.3 Australia 7.4.5.3.1 Market size and forecast, by Type 7.4.5.3.2 Market size and forecast, by Age Group 7.4.5.3.3 Market size and forecast, by End User 7.4.5.4 India 7.4.5.4.1 Market size and forecast, by Type 7.4.5.4.2 Market size and forecast, by Age Group 7.4.5.4.3 Market size and forecast, by End User 7.4.5.5 South Korea 7.4.5.5.1 Market size and forecast, by Type 7.4.5.5.2 Market size and forecast, by Age Group 7.4.5.5.3 Market size and forecast, by End User 7.4.5.6 Rest Of Asia Pacific 7.4.5.6.1 Market size and forecast, by Type 7.4.5.6.2 Market size and forecast, by Age Group 7.4.5.6.3 Market size and forecast, by End User 7.5 LAMEA 7.5.1 Key trends and opportunities 7.5.2 LAMEA Market size and forecast, by Type 7.5.3 LAMEA Market size and forecast, by Age Group 7.5.4 LAMEA Market size and forecast, by End User 7.5.5 LAMEA Market size and forecast, by country 7.5.5.1 Brazil 7.5.5.1.1 Market size and forecast, by Type 7.5.5.1.2 Market size and forecast, by Age Group 7.5.5.1.3 Market size and forecast, by End User 7.5.5.2 Saudi Arabia 7.5.5.2.1 Market size and forecast, by Type 7.5.5.2.2 Market size and forecast, by Age Group 7.5.5.2.3 Market size and forecast, by End User 7.5.5.3 South Africa 7.5.5.3.1 Market size and forecast, by Type 7.5.5.3.2 Market size and forecast, by Age Group 7.5.5.3.3 Market size and forecast, by End User 7.5.5.4 Rest of LAMEA 7.5.5.4.1 Market size and forecast, by Type 7.5.5.4.2 Market size and forecast, by Age Group 7.5.5.4.3 Market size and forecast, by End User CHAPTER 8: COMPANY LANDSCAPE 8.1. Introduction 8.2. Top winning strategies 8.3. Product Mapping of Top 10 Player 8.4. Competitive Dashboard 8.5. Competitive Heatmap 8.6. Key developments CHAPTER 9: COMPANY PROFILES 9.1 Bayer AG 9.1.1 Company overview 9.1.2 Company snapshot 9.1.3 Operating business segments 9.1.4 Product portfolio 9.1.5 Business performance 9.1.6 Key strategic moves and developments 9.2 CooperSurgical Inc 9.2.1 Company overview 9.2.2 Company snapshot 9.2.3 Operating business segments 9.2.4 Product portfolio 9.2.5 Business performance 9.2.6 Key strategic moves and developments 9.3 DKT International 9.3.1 Company overview 9.3.2 Company snapshot 9.3.3 Operating business segments 9.3.4 Product portfolio 9.3.5 Business performance 9.3.6 Key strategic moves and developments 9.4 Mona Lisa NV 9.4.1 Company overview 9.4.2 Company snapshot 9.4.3 Operating business segments 9.4.4 Product portfolio 9.4.5 Business performance 9.4.6 Key strategic moves and developments 9.5 Pregna International Limited 9.5.1 Company overview 9.5.2 Company snapshot 9.5.3 Operating business segments 9.5.4 Product portfolio 9.5.5 Business performance 9.5.6 Key strategic moves and developments 9.6 Prosan International BV 9.6.1 Company overview 9.6.2 Company snapshot 9.6.3 Operating business segments 9.6.4 Product portfolio 9.6.5 Business performance 9.6.6 Key strategic moves and developments 9.7 Abviee Inc 9.7.1 Company overview 9.7.2 Company snapshot 9.7.3 Operating business segments 9.7.4 Product portfolio 9.7.5 Business performance 9.7.6 Key strategic moves and developments 9.8 Eurogine, S.L. 9.8.1 Company overview 9.8.2 Company snapshot 9.8.3 Operating business segments 9.8.4 Product portfolio 9.8.5 Business performance 9.8.6 Key strategic moves and developments 9.9 Viatris Inc 9.9.1 Company overview 9.9.2 Company snapshot 9.9.3 Operating business segments 9.9.4 Product portfolio 9.9.5 Business performance 9.9.6 Key strategic moves and developments 9.10 Mona Lisa N.V., 9.10.1 Company overview 9.10.2 Company snapshot 9.10.3 Operating business segments 9.10.4 Product portfolio 9.10.5 Business performance 9.10.6 Key strategic moves and developments
SummaryThe global intrauterine devices market was valued at $2,992.73 million in 2021 and is projected to reach $4,374.3 million by 2031, registering a CAGR of 3.8% from 2022 to 2031. An intrauterine device (IUD) is a small plastic T-shaped device used for birth control. It is inserted into the uterus where it stays to prevent pregnancy. The intrauterine device is one form of long-acting reversible birth control (LARC) that is also safe and effective in adolescents as well as those who have not previously had children. Once an intrauterine device is removed, even after long-term use, fertility returns to normal rapidly. There are two types of intrauterine devices available on the market including nonhormonal: copper-containing IUD and hormonal: progestogen-releasing IUD to prevent unwanted pregnancies. Table of ContentsCHAPTER 1:INTRODUCTION1.1.Report description 1.2.Key market segments 1.3.Key benefits to the stakeholders 1.4.Research Methodology 1.4.1.Secondary research 1.4.2.Primary research 1.4.3.Analyst tools and models CHAPTER 2:EXECUTIVE SUMMARY 2.1.Key findings of the study 2.2.CXO Perspective CHAPTER 3:MARKET OVERVIEW 3.1.Market definition and scope 3.2.Key findings 3.2.1.Top investment pockets 3.3.Porter’s five forces analysis 3.4.Top player positioning 3.5.Market dynamics 3.5.1.Drivers 3.5.2.Restraints 3.5.3.Opportunities 3.6.COVID-19 Impact Analysis on the market CHAPTER 4: INTRAUTERINE DEVICES MARKET, BY TYPE 4.1 Overview 4.1.1 Market size and forecast 4.2 Nonhormonal: Copper-containing IUD 4.2.1 Key market trends, growth factors and opportunities 4.2.2 Market size and forecast, by region 4.2.3 Market analysis by country 4.3 Hormonal: Progestogen-releasing IUD 4.3.1 Key market trends, growth factors and opportunities 4.3.2 Market size and forecast, by region 4.3.3 Market analysis by country CHAPTER 5: INTRAUTERINE DEVICES MARKET, BY AGE GROUP 5.1 Overview 5.1.1 Market size and forecast 5.2 15-24 years 5.2.1 Key market trends, growth factors and opportunities 5.2.2 Market size and forecast, by region 5.2.3 Market analysis by country 5.3 25-34 years 5.3.1 Key market trends, growth factors and opportunities 5.3.2 Market size and forecast, by region 5.3.3 Market analysis by country 5.4 35-44 years 5.4.1 Key market trends, growth factors and opportunities 5.4.2 Market size and forecast, by region 5.4.3 Market analysis by country 5.5 Above 44 years 5.5.1 Key market trends, growth factors and opportunities 5.5.2 Market size and forecast, by region 5.5.3 Market analysis by country CHAPTER 6: INTRAUTERINE DEVICES MARKET, BY END USER 6.1 Overview 6.1.1 Market size and forecast 6.2 Hospitals 6.2.1 Key market trends, growth factors and opportunities 6.2.2 Market size and forecast, by region 6.2.3 Market analysis by country 6.3 Clinics 6.3.1 Key market trends, growth factors and opportunities 6.3.2 Market size and forecast, by region 6.3.3 Market analysis by country 6.4 Community Health Care Centres 6.4.1 Key market trends, growth factors and opportunities 6.4.2 Market size and forecast, by region 6.4.3 Market analysis by country 6.5 Others 6.5.1 Key market trends, growth factors and opportunities 6.5.2 Market size and forecast, by region 6.5.3 Market analysis by country CHAPTER 7: INTRAUTERINE DEVICES MARKET, BY REGION 7.1 Overview 7.1.1 Market size and forecast 7.2 North America 7.2.1 Key trends and opportunities 7.2.2 North America Market size and forecast, by Type 7.2.3 North America Market size and forecast, by Age Group 7.2.4 North America Market size and forecast, by End User 7.2.5 North America Market size and forecast, by country 7.2.5.1 U.S. 7.2.5.1.1 Market size and forecast, by Type 7.2.5.1.2 Market size and forecast, by Age Group 7.2.5.1.3 Market size and forecast, by End User 7.2.5.2 Canada 7.2.5.2.1 Market size and forecast, by Type 7.2.5.2.2 Market size and forecast, by Age Group 7.2.5.2.3 Market size and forecast, by End User 7.2.5.3 Mexico 7.2.5.3.1 Market size and forecast, by Type 7.2.5.3.2 Market size and forecast, by Age Group 7.2.5.3.3 Market size and forecast, by End User 7.3 Europe 7.3.1 Key trends and opportunities 7.3.2 Europe Market size and forecast, by Type 7.3.3 Europe Market size and forecast, by Age Group 7.3.4 Europe Market size and forecast, by End User 7.3.5 Europe Market size and forecast, by country 7.3.5.1 Germany 7.3.5.1.1 Market size and forecast, by Type 7.3.5.1.2 Market size and forecast, by Age Group 7.3.5.1.3 Market size and forecast, by End User 7.3.5.2 France 7.3.5.2.1 Market size and forecast, by Type 7.3.5.2.2 Market size and forecast, by Age Group 7.3.5.2.3 Market size and forecast, by End User 7.3.5.3 U.K. 7.3.5.3.1 Market size and forecast, by Type 7.3.5.3.2 Market size and forecast, by Age Group 7.3.5.3.3 Market size and forecast, by End User 7.3.5.4 Italy 7.3.5.4.1 Market size and forecast, by Type 7.3.5.4.2 Market size and forecast, by Age Group 7.3.5.4.3 Market size and forecast, by End User 7.3.5.5 Spain 7.3.5.5.1 Market size and forecast, by Type 7.3.5.5.2 Market size and forecast, by Age Group 7.3.5.5.3 Market size and forecast, by End User 7.3.5.6 Rest of Europe 7.3.5.6.1 Market size and forecast, by Type 7.3.5.6.2 Market size and forecast, by Age Group 7.3.5.6.3 Market size and forecast, by End User 7.4 Asia-Pacific 7.4.1 Key trends and opportunities 7.4.2 Asia-Pacific Market size and forecast, by Type 7.4.3 Asia-Pacific Market size and forecast, by Age Group 7.4.4 Asia-Pacific Market size and forecast, by End User 7.4.5 Asia-Pacific Market size and forecast, by country 7.4.5.1 Japan 7.4.5.1.1 Market size and forecast, by Type 7.4.5.1.2 Market size and forecast, by Age Group 7.4.5.1.3 Market size and forecast, by End User 7.4.5.2 China 7.4.5.2.1 Market size and forecast, by Type 7.4.5.2.2 Market size and forecast, by Age Group 7.4.5.2.3 Market size and forecast, by End User 7.4.5.3 Australia 7.4.5.3.1 Market size and forecast, by Type 7.4.5.3.2 Market size and forecast, by Age Group 7.4.5.3.3 Market size and forecast, by End User 7.4.5.4 India 7.4.5.4.1 Market size and forecast, by Type 7.4.5.4.2 Market size and forecast, by Age Group 7.4.5.4.3 Market size and forecast, by End User 7.4.5.5 South Korea 7.4.5.5.1 Market size and forecast, by Type 7.4.5.5.2 Market size and forecast, by Age Group 7.4.5.5.3 Market size and forecast, by End User 7.4.5.6 Rest Of Asia Pacific 7.4.5.6.1 Market size and forecast, by Type 7.4.5.6.2 Market size and forecast, by Age Group 7.4.5.6.3 Market size and forecast, by End User 7.5 LAMEA 7.5.1 Key trends and opportunities 7.5.2 LAMEA Market size and forecast, by Type 7.5.3 LAMEA Market size and forecast, by Age Group 7.5.4 LAMEA Market size and forecast, by End User 7.5.5 LAMEA Market size and forecast, by country 7.5.5.1 Brazil 7.5.5.1.1 Market size and forecast, by Type 7.5.5.1.2 Market size and forecast, by Age Group 7.5.5.1.3 Market size and forecast, by End User 7.5.5.2 Saudi Arabia 7.5.5.2.1 Market size and forecast, by Type 7.5.5.2.2 Market size and forecast, by Age Group 7.5.5.2.3 Market size and forecast, by End User 7.5.5.3 South Africa 7.5.5.3.1 Market size and forecast, by Type 7.5.5.3.2 Market size and forecast, by Age Group 7.5.5.3.3 Market size and forecast, by End User 7.5.5.4 Rest of LAMEA 7.5.5.4.1 Market size and forecast, by Type 7.5.5.4.2 Market size and forecast, by Age Group 7.5.5.4.3 Market size and forecast, by End User CHAPTER 8: COMPANY LANDSCAPE 8.1. Introduction 8.2. Top winning strategies 8.3. Product Mapping of Top 10 Player 8.4. Competitive Dashboard 8.5. Competitive Heatmap 8.6. Key developments CHAPTER 9: COMPANY PROFILES 9.1 Bayer AG 9.1.1 Company overview 9.1.2 Company snapshot 9.1.3 Operating business segments 9.1.4 Product portfolio 9.1.5 Business performance 9.1.6 Key strategic moves and developments 9.2 CooperSurgical Inc 9.2.1 Company overview 9.2.2 Company snapshot 9.2.3 Operating business segments 9.2.4 Product portfolio 9.2.5 Business performance 9.2.6 Key strategic moves and developments 9.3 DKT International 9.3.1 Company overview 9.3.2 Company snapshot 9.3.3 Operating business segments 9.3.4 Product portfolio 9.3.5 Business performance 9.3.6 Key strategic moves and developments 9.4 Mona Lisa NV 9.4.1 Company overview 9.4.2 Company snapshot 9.4.3 Operating business segments 9.4.4 Product portfolio 9.4.5 Business performance 9.4.6 Key strategic moves and developments 9.5 Pregna International Limited 9.5.1 Company overview 9.5.2 Company snapshot 9.5.3 Operating business segments 9.5.4 Product portfolio 9.5.5 Business performance 9.5.6 Key strategic moves and developments 9.6 Prosan International BV 9.6.1 Company overview 9.6.2 Company snapshot 9.6.3 Operating business segments 9.6.4 Product portfolio 9.6.5 Business performance 9.6.6 Key strategic moves and developments 9.7 Abviee Inc 9.7.1 Company overview 9.7.2 Company snapshot 9.7.3 Operating business segments 9.7.4 Product portfolio 9.7.5 Business performance 9.7.6 Key strategic moves and developments 9.8 Eurogine, S.L. 9.8.1 Company overview 9.8.2 Company snapshot 9.8.3 Operating business segments 9.8.4 Product portfolio 9.8.5 Business performance 9.8.6 Key strategic moves and developments 9.9 Viatris Inc 9.9.1 Company overview 9.9.2 Company snapshot 9.9.3 Operating business segments 9.9.4 Product portfolio 9.9.5 Business performance 9.9.6 Key strategic moves and developments 9.10 Mona Lisa N.V., 9.10.1 Company overview 9.10.2 Company snapshot 9.10.3 Operating business segments 9.10.4 Product portfolio 9.10.5 Business performance 9.10.6 Key strategic moves and developments
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（在宅・地域医療）の最新刊レポート
Allied Market Research 社の最新刊レポート
本レポートと同じKEY WORD（hospitals）の最新刊レポート
よくあるご質問Allied Market Research社はどのような調査会社ですか?アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/07/05 10:26 162.17 円 175.82 円 209.73 円 |
